FRANKLIN STREET ADVISORS INC /NC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 118 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN STREET ADVISORS INC /NC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$38,000
-29.6%
20,5000.0%0.01%
-28.6%
Q2 2019$54,000
+1.9%
20,5000.0%0.01%0.0%
Q1 2019$53,000
+12.8%
20,5000.0%0.01%0.0%
Q4 2018$47,000
-28.8%
20,5000.0%0.01%
-22.2%
Q3 2018$66,000
+11.9%
20,500
-2.4%
0.01%0.0%
Q2 2018$59,000
-16.9%
21,000
+5.0%
0.01%
-18.2%
Q1 2018$71,000
-9.0%
20,0000.0%0.01%
-8.3%
Q4 2017$78,000
+52.9%
20,0000.0%0.01%
+50.0%
Q3 2017$51,000
-7.3%
20,0000.0%0.01%
-11.1%
Q2 2017$55,000
-16.7%
20,0000.0%0.01%
-25.0%
Q1 2017$66,000
+37.5%
20,0000.0%0.01%
+50.0%
Q4 2016$48,000
-34.2%
20,0000.0%0.01%
-38.5%
Q3 2016$73,000
+62.2%
20,0000.0%0.01%
+44.4%
Q2 2016$45,000
+7.1%
20,0000.0%0.01%
+12.5%
Q1 2016$42,000
-31.1%
20,0000.0%0.01%
-33.3%
Q4 2015$61,000
+24.5%
20,0000.0%0.01%
+20.0%
Q3 2015$49,000
-23.4%
20,0000.0%0.01%
-9.1%
Q2 2015$64,000
-9.9%
20,0000.0%0.01%
-15.4%
Q1 2015$71,000
-55.3%
20,000
-71.4%
0.01%
-56.7%
Q4 2014$159,000
-51.8%
70,000
-58.8%
0.03%
-52.4%
Q3 2014$330,000
-46.6%
170,0000.0%0.06%
-46.6%
Q2 2014$618,000
+1161.2%
170,000
+1159.3%
0.12%
+972.7%
Q3 2013$49,000
-31.0%
13,500
-37.2%
0.01%
-35.3%
Q2 2013$71,00021,5000.02%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders